NCT00594321撤回不适用
Evaluation of Fracture Fixation With Energy and Cement in Tumors of the Spine
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- The primary endpoint is cement leakage as determined radiographically (CT). will be cement leakage measured by CT.
研究概览
简要总结
The objective of the clinical trial is to evaluate the SPACE 360 Delivery System using SPACE CpsXL Bone Cement compared to standard vertebroplasty in the treatment of pathological fractures of the spine caused by metastatic tumors of the spine, myeloma, or lymphoma. Up to a total of three levels per patient may be included or five levels for multiple myeloma. The control group will be standard vertebroplasty.
详细描述
The primary endpoint is cement leakage as determined radiographically (CT). will be cement leakage measured by CT. Secondary endpoints are reduction of pain (VAS) and quality of life measurements (Oswestry disability index).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Males and females between 18 and 85 years of age
- •Pain at one to three levels, or five for multiple myeloma (pain on palpation/percussion over fractured vertebral body) requiring treatment
- •Spinal metastasis (except renal cell), myeloma, or lymphoma of the spine
- •Pathological fracture(s), T5-L5, with bone marrow edema imaged by magnetic resonance imaging (MRI)
- •Visual Analog Scale (VAS) for pain of > 4 on a scale of 0 to 10
- •Oswestry score of at least a moderate disability (21-40%)
- •No major surgery to the spine planned for at least 1 month following enrollment - Defined as a procedure the magnitude of a laminectomy or more
- •Life expectancy of > 6 months.
- •Patient has sufficient mental capacity to comply with the protocol requirements
- •Availability for all study visits and phone calls
- •Understands the potential risks and benefits of participating in the study and is willing to provide written informed consent
- •Pathological vertebral fracture with 20-70% compression (compared to adjacent normal vertebral body)
- •Fracture age < 6 months
- •Signal on MRI consistent with non-healed fracture
- •Female subjects must either be no longer capable of reproduction or taking acceptable measures to prevent pregnancy during the study
- •Subject must be willing and able to comply with specified follow-up evaluations
排除标准
- •Primary tumors other than plasmacytoma
- •Renal cell tumors
- •More than 80% compression of the vertebrae
- •Level(s) above T7 to treat
- •Fractures due osteoporosis
- •Burst fracture
- •Pedicle fracture
- •Neurological deficit associated with the fracture
- •Kyphosis > 30°
- •Translation > 4 mm
- •Instability of posterior wall with symptomatic displacement of fragment into spinal canal or significant canal compromise
- •Intercostal nerve compression
- •Active systemic or local infection at the level(s) to be treated
- •Uncontrolled coagulopathy
- •Cannot temporarily discontinue anticoagulation therapy
- •Known allergy to device materials / PMMA
- •Radiculopathy
- •Cord compression or canal compromise requiring surgery for decompression
- •High energy trauma
- •Severe cardiopulmonary deficiencies - Defined as not being able to tolerate general anesthesia (although the likelihood is local anesthesia will be used)
- •Vertebra plana defined as vertebral body height of 20% or less compared to the nearest normal level
- •Disabling back pain secondary to another cause that may interfere with accurate data collection
- •Subjects who are known to be pregnant (pregnancy test required within 10 days of treatment) or lactating
- •Females capable of reproduction and will not take acceptable measures to prevent reproduction during the study
- •Subjects who test positive for HIV
- •Currently enrolled in another investigational device trial (IDE) that has not completed the protocol required primary follow-up period (excludes 15 year follow-up of gene therapy trials)
- •Lesions involving the pedicle
- •Platelet count of < 50,000
结局指标
主要结局
The primary endpoint is cement leakage as determined radiographically (CT). will be cement leakage measured by CT.
时间窗: 3 years
次要结局
- Secondary endpoints are reduction of pain (VAS) and quality of life measurements (Oswestry disability index).(3 years)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
X-ray Evaluation of the Effectiveness of the Atlas Correction in Patients With Chronic Subluxation of the AtlasSubluxation and Dislocation of C0/C1 Cervical VertebraeNCT05986656Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia46
Unknown
不适用
The FLiP Study, a Pilot Cluster Randomized TrialFemur FractureNCT03868280Hamilton Health Sciences Corporation100
进行中（未招募）
不适用
PMCF Neo Pedicle Screw and Cage SystemsTraumaPseudoarthrosis of SpineDegenerative Disc DiseaseSpondylolisthesisSpinal StenosisSpinal TumorNCT03956537Neo Medical SA150
已完成
不适用
Efficacy of Skeletal Anchorage (MINISCREW)Tooth Extraction Status NosNCT01025141Assistance Publique - Hôpitaux de Paris99
暂停
不适用
Patient-centered Assessment of the Effects of Powered Exoskeleton Use in People With Spinal Cord InjurySpinal Cord InjuriesNCT05811884Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro18